News from the Johns Hopkins Division of Gastroenterology and Hepatology
Nicholas Zachos and his team are the first to cultivate a primary human macrophage-enteroid system, which allows researchers to see, in real time, how the gut fights against infection.
Johns Hopkins research suggests that identification of particular genetic mutations could better predict risk and lead to improved survival rates.
Johns Hopkins research suggests that women with IBD who discontinue infliximab early in pregnancy are more likely to flare, while continuation of the drug throughout term is not associated with poor outcomes for mothers or babies.
